Botox-maker Allergan sees profits drop slightly in third quarter

Allergan, the maker of anti-wrinkle treatment Botox, saw profits slightly lower in the third quarter.

The company which employs close to 1,000 people in Westport, Co Mayo, posted a profit of $249.4m, or 82 cents per share, in the third quarter compared with $249.8m (€194m), or 81 cents per share, a year earlier.

Allergan also said it was exploring a sale of its obesity business on falling sales of the only product in the unit.

Sales of Lap-Band fell 21% to $122.7m, while sales of most of Allergan’s products increased during the third quarter.

The unit accounted for about 4% of Allergan’s total revenue in 2011.

The company expects sales of $160m from its obesity intervention products unit for the full year. It sees total product net sales of between $5.69bn and $5.77bn.

US health regulators recently approved two weight loss drugs, after a gap of 13 years, underlining the pressure on the Food and Drug Administration to approve treatments for obesity as about two thirds of Americans are considered overweight or obese.

Lap-Band has an inflatable band placed around the stomach through a minimally invasive surgery, creating a pouch that limits or reduces food consumption.

Adjusting for charges that include restructuring, research and development, and amortisation of acquired intangible assets, the company earned $1.06 per share.

Revenue rose 6% to $1.4bn. Analysts were expecting a profit of $1.04 per share, excluding special items, on revenue of $1.43bn, according to Thomson Reuters.

Shares of the California-based company, which has a market capitalisation of $21.18bn dollars, closed at $91.64 on Friday on the New York Stock Exchange.

More in this section

Lunchtime
News Wrap

A lunchtime summary of content highlights on the Irish Examiner website. Delivered at 1pm each day.

Sign up

Discover the

Install our free app today

Available on

Revoiced
Newsletter

Our Covid-free newsletter brings together some of the best bits from irishexaminer.com, as chosen by our editor, direct to your inbox every Monday.

Sign up

HOME DELIVERY SERVICE

Have the Irish Examiner delivered to your door. No delivery charge. Just pay the cover price.